Middle East Healthcare Co. (Saudi German Health) reported a surge in 2022 net profit after Zakat and tax of SAR 75.2 million, compared to SAR 17.2 million in 2021.
Item | 2021 | 2022 | Change |
---|---|---|---|
Revenues | 1,872.62 | 2,151.74 | 14.9 % |
Gross Income | 608.18 | 680.01 | 11.8 % |
Operating Income | 40.50 | 140.34 | 246.5 % |
Net Income | 17.20 | 75.18 | 337.1 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.19 | 0.82 | 337.1 % |
The profit spike was spurred by an increase in number of patients both in outpatient and inpatient clinics, higher revenue due to the revised prices with major customer, accreditation and case mix, along with better efficiency due to ramp up of new facilities.
Item | Q4 2021 | Q4 2022 | Change |
---|---|---|---|
Revenues | 498.95 | 617.96 | 23.9 % |
Gross Income | 160.11 | 204.01 | 27.4 % |
Operating Income | (7.03) | 57.96 | 924.3 % |
Net Income | (18.39) | 33.16 | 280.3 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | (0.20) | 0.36 | 280.3 % |
Item | Q3 2022 | Q4 2022 | Change |
---|---|---|---|
Revenues | 512.37 | 617.96 | 20.6 % |
Gross Income | 152.21 | 204.01 | 34.0 % |
Operating Income | 26.26 | 57.96 | 120.8 % |
Net Income | 11.11 | 33.16 | 198.6 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.12 | 0.36 | 198.6 % |
In Q4 2022, the healthcare services provider swung to a net profit of SAR 33.2 million, against a net loss of SAR 18.39 million in the prior-year period.
Compared to the previous quarter, net profit more than doubled from SAR 11.11 million.
Shareholders’ equity, after minority interest, increased to SAR 1.36 billion as of Dec. 31, 2022, from SAR 1.25 billion a year earlier.
In 2022, SGH opened three new healthcare facilities in Jeddah, Abha and Makkah, growing the group’s network to eight hospitals and two polyclinics across seven cities in the Kingdom.
The three new facilities contributed negative results of SAR 54 million in the 12-month period.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
Q1 2014 | 359.18 | - | 199.49 | - | 75.11 | - |
Q2 2014 | 347.08 | - | 185.78 | - | 88.17 | - |
Q3 2014 | 323.16 | - | 174.49 | - | 71.53 | - |
Q4 2014 | 369.34 | - | 190.01 | - | 78.37 | - |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
Q1 2015 | 391.64 | 9.0 % | 208.99 | 4.8 % | 102.89 | 37.0 % |
Q2 2015 | 372.00 | 7.2 % | 203.88 | 9.7 % | 89.24 | 1.2 % |
Q3 2015 | 352.20 | 9.0 % | 183.23 | 5.0 % | 88.21 | 23.3 % |
Q4 2015 | 418.69 | 13.4 % | 214.04 | 12.6 % | 97.86 | 24.9 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
Q1 2016 | 421.52 | 7.6 % | 216.62 | 3.7 % | 103.68 | 0.8 % |
Q2 2016 | 410.07 | 10.2 % | 212.49 | 4.2 % | 76.56 | (14.2 %) |
Q3 2016 | 379.09 | 7.6 % | 199.40 | 8.8 % | 91.10 | 3.3 % |
Q4 2016 | 404.96 | (3.3 %) | 199.88 | (6.6 %) | 87.04 | (11.1 %) |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
Q1 2017 | 393.53 | (6.6 %) | 180.47 | (16.7 %) | 107.04 | 3.2 % |
Q2 2017 | 351.28 | (14.3 %) | 138.63 | (34.8 %) | 58.97 | (23.0 %) |
Q3 2017 | 352.98 | (6.9 %) | 133.30 | (33.1 %) | 55.70 | (38.9 %) |
Q4 2017 | 364.60 | (10.0 %) | 145.47 | (27.2 %) | 73.06 | (16.1 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
Q1 2018 | 395.11 | 0.4 % | 160.42 | (11.1 %) | 85.82 | (19.8 %) |
Q2 2018 | 346.13 | (1.5 %) | 116.91 | (15.7 %) | 31.66 | (46.3 %) |
Q3 2018 | 338.77 | (4.0 %) | 111.87 | (16.1 %) | 21.29 | (61.8 %) |
Q4 2018 | 310.68 | (14.8 %) | 111.56 | (23.3 %) | 23.96 | (67.2 %) |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 162.73 | (44.8 %) |
Q1 2019 | 350.18 | (11.4 %) | 101.63 | (36.6 %) | 18.31 | (78.7 %) |
Q2 2019 | 353.20 | 2.0 % | 102.76 | (12.1 %) | 7.58 | (76.0 %) |
Q3 2019 | 386.76 | 14.2 % | 119.96 | 7.2 % | 33.31 | 56.5 % |
Q4 2019 | 406.51 | 30.8 % | 148.59 | 33.2 % | 44.06 | 83.9 % |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 103.27 | (36.5 %) |
Q1 2020 | 436.31 | 24.6 % | 146.86 | 44.5 % | 24.36 | 33.0 % |
Q2 2020 | 373.26 | 5.7 % | 120.49 | 17.3 % | 23.73 | 212.9 % |
Q3 2020 | 492.13 | 27.2 % | 171.91 | 43.3 % | 42.12 | 26.4 % |
Q4 2020 | 448.89 | 10.4 % | 139.12 | (6.4 %) | 17.20 | (61.0 %) |
2020 | 1,750.59 | 17.0 % | 578.37 | 22.3 % | 107.41 | 4.0 % |
Q1 2021 | 418.37 | (4.1 %) | 123.16 | (16.1 %) | (0.04) | (100.2 %) |
Q2 2021 | 456.57 | 22.3 % | 152.64 | 26.7 % | 20.12 | (15.2 %) |
Q3 2021 | 498.73 | 1.3 % | 172.27 | 0.2 % | 27.46 | (34.8 %) |
Q4 2021 | 498.95 | 11.2 % | 160.11 | 15.1 % | (7.03) | (140.9 %) |
2021 | 1,872.62 | 7.0 % | 608.18 | 5.2 % | 40.50 | (62.3 %) |
Q1 2022 | 513.32 | 22.7 % | 165.02 | 34.0 % | 35.28 | 90551.0 % |
Q2 2022 | 508.09 | 11.3 % | 158.77 | 4.0 % | 21.77 | 8.2 % |
Q3 2022 | 512.37 | 2.7 % | 152.21 | (11.6 %) | 26.26 | (4.4 %) |
Q4 2022 | 617.96 | 23.9 % | 204.01 | 27.4 % | 57.96 | 924.3 % |
2022 | 2,151.74 | 14.9 % | 680.01 | 11.8 % | 140.34 | 246.5 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 162.73 | (44.8 %) |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 103.27 | (36.5 %) |
2020 | 1,750.59 | 17.0 % | 578.37 | 22.3 % | 107.41 | 4.0 % |
2021 | 1,872.62 | 7.0 % | 608.18 | 5.2 % | 40.50 | (62.3 %) |
2022 | 2,151.74 | 14.9 % | 680.01 | 11.8 % | 140.34 | 246.5 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
Q1 2014 | 80.16 | - | 0.87 | - | 80.16 | 0.87 |
Q2 2014 | 92.80 | - | 1.01 | - | 92.80 | 1.01 |
Q3 2014 | 74.36 | - | 0.81 | - | 74.36 | 0.81 |
Q4 2014 | 84.64 | - | 0.92 | - | 84.64 | 0.92 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
Q1 2015 | 105.39 | 31.5 % | 1.15 | - | 105.39 | 1.15 |
Q2 2015 | 91.79 | (1.1 %) | 1.00 | - | 91.79 | 1.00 |
Q3 2015 | 90.75 | 22.0 % | 0.99 | - | 90.75 | 0.99 |
Q4 2015 | 102.32 | 20.9 % | 1.11 | - | 102.32 | 1.11 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
Q1 2016 | 104.20 | (1.1 %) | 1.13 | - | 104.20 | 1.13 |
Q2 2016 | 74.07 | (19.3 %) | 0.80 | - | 74.07 | 0.80 |
Q3 2016 | 99.64 | 9.8 % | 1.08 | - | 99.64 | 1.08 |
Q4 2016 | 84.73 | (17.2 %) | 0.92 | - | 84.73 | 0.92 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
Q1 2017 | 109.97 | 5.5 % | 1.19 | - | 109.97 | 1.19 |
Q2 2017 | 61.95 | (16.4 %) | 0.67 | - | 61.95 | 0.67 |
Q3 2017 | 64.88 | (34.9 %) | 0.70 | - | 64.88 | 0.70 |
Q4 2017 | 82.69 | (2.4 %) | 0.90 | - | 82.69 | 0.90 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
Q1 2018 | 87.13 | (20.8 %) | 0.95 | - | 87.13 | 0.95 |
Q2 2018 | 34.27 | (44.7 %) | 0.37 | - | 34.27 | 0.37 |
Q3 2018 | 20.16 | (68.9 %) | 0.22 | - | 20.16 | 0.22 |
Q4 2018 | 30.69 | (62.9 %) | 0.33 | - | 30.69 | 0.33 |
2018 | 172.25 | (46.1 %) | 1.87 | - | 172.25 | 1.87 |
Q1 2019 | 14.59 | (83.3 %) | 0.16 | - | 14.59 | 0.16 |
Q2 2019 | 12.28 | (64.2 %) | 0.13 | - | 12.28 | 0.13 |
Q3 2019 | 33.23 | 64.8 % | 0.36 | - | 33.23 | 0.36 |
Q4 2019 | 37.47 | 22.1 % | 0.41 | (8.00) | 45.47 | 0.49 |
2019 | 97.57 | (43.4 %) | 1.06 | (8.00) | 105.57 | 1.15 |
Q1 2020 | 21.18 | 45.2 % | 0.23 | - | 21.18 | 0.23 |
Q2 2020 | 16.35 | 33.2 % | 0.18 | - | 16.35 | 0.18 |
Q3 2020 | 34.91 | 5.1 % | 0.38 | - | 34.91 | 0.38 |
Q4 2020 | 9.54 | (74.5 %) | 0.10 | - | 9.54 | 0.10 |
2020 | 81.99 | (16.0 %) | 0.89 | - | 81.99 | 0.89 |
Q1 2021 | 12.10 | (42.9 %) | 0.13 | 17.53 | (5.43) | (0.06) |
Q2 2021 | 9.14 | (44.1 %) | 0.10 | (0.48) | 9.62 | 0.10 |
Q3 2021 | 14.35 | (58.9 %) | 0.16 | (4.16) | 18.51 | 0.20 |
Q4 2021 | (18.39) | (292.8 %) | (0.20) | 0.84 | (19.24) | (0.21) |
2021 | 17.20 | (79.0 %) | 0.19 | 13.74 | 3.46 | 0.04 |
Q1 2022 | 20.49 | 69.3 % | 0.22 | - | 20.49 | 0.22 |
Q2 2022 | 10.43 | 14.1 % | 0.11 | - | 10.43 | 0.11 |
Q3 2022 | 11.11 | (22.6 %) | 0.12 | - | 11.11 | 0.12 |
Q4 2022 | 33.16 | 280.3 % | 0.36 | - | 33.16 | 0.36 |
2022 | 75.18 | 337.1 % | 0.82 | - | 75.18 | 0.82 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
2018 | 172.25 | (46.1 %) | 1.87 | - | 172.25 | 1.87 |
2019 | 97.57 | (43.4 %) | 1.06 | (8.00) | 105.57 | 1.15 |
2020 | 81.99 | (16.0 %) | 0.89 | - | 81.99 | 0.89 |
2021 | 17.20 | (79.0 %) | 0.19 | 13.74 | 3.46 | 0.04 |
2022 | 75.18 | 337.1 % | 0.82 | - | 75.18 | 0.82 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
2013 | 51.97 % | 21.68 % | 16.56 % |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | 53.60 % | 25.57 % | 23.73 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
Q1 2015 | 53.05 % | 27.10 % | 24.96 % |
Q2 2015 | 53.39 % | 26.84 % | 24.46 % |
Q3 2015 | 52.93 % | 27.56 % | 25.09 % |
Q4 2015 | 52.79 % | 28.05 % | 25.43 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
Q1 2016 | 52.27 % | 27.77 % | 24.87 % |
Q2 2016 | 51.57 % | 26.50 % | 23.17 % |
Q3 2016 | 51.71 % | 26.41 % | 23.34 % |
Q4 2016 | 51.27 % | 26.12 % | 22.45 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
Q1 2017 | 49.90 % | 26.91 % | 23.20 % |
Q2 2017 | 46.99 % | 27.02 % | 23.30 % |
Q3 2017 | 43.41 % | 25.39 % | 21.40 % |
Q4 2017 | 40.88 % | 25.40 % | 21.85 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
Q1 2018 | 39.47 % | 24.17 % | 20.26 % |
Q2 2018 | 38.12 % | 22.54 % | 18.44 % |
Q3 2018 | 37.01 % | 20.57 % | 15.52 % |
Q4 2018 | 36.01 % | 18.10 % | 12.39 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
Q1 2019 | 32.84 % | 13.74 % | 7.41 % |
Q2 2019 | 31.62 % | 12.25 % | 5.74 % |
Q3 2019 | 31.12 % | 12.85 % | 6.48 % |
Q4 2019 | 31.60 % | 13.48 % | 7.05 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
Q1 2020 | 32.74 % | 13.41 % | 7.09 % |
Q2 2020 | 33.43 % | 14.66 % | 7.25 % |
Q3 2020 | 34.41 % | 14.80 % | 6.90 % |
Q4 2020 | 33.04 % | 13.40 % | 4.68 % |
2020 | 33.04 % | 13.40 % | 4.68 % |
Q1 2021 | 32.01 % | 12.65 % | 3.20 % |
Q2 2021 | 32.32 % | 11.91 % | 2.68 % |
Q3 2021 | 32.22 % | 11.12 % | 1.77 % |
Q4 2021 | 32.48 % | 9.71 % | 0.18 % |
2021 | 32.48 % | 9.71 % | 0.18 % |
Q1 2022 | 33.04 % | 10.93 % | 1.49 % |
Q2 2022 | 32.50 % | 10.71 % | 1.50 % |
Q3 2022 | 31.29 % | 10.75 % | 1.12 % |
Q4 2022 | 31.60 % | 13.35 % | 3.49 % |
2022 | 31.60 % | 13.31 % | 3.49 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2013 | 51.97 % | 21.68 % | 16.56 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
2020 | 33.04 % | 13.40 % | 4.68 % |
2021 | 32.48 % | 9.71 % | 0.18 % |
2022 | 31.60 % | 13.31 % | 3.49 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | 55.54 % | 23.76 % | 22.32 % |
Q2 2014 | 53.53 % | 28.54 % | 26.74 % |
Q3 2014 | 54.00 % | 25.72 % | 23.01 % |
Q4 2014 | 51.45 % | 24.43 % | 22.92 % |
Q1 2015 | 53.36 % | 29.47 % | 26.91 % |
Q2 2015 | 54.81 % | 27.44 % | 24.67 % |
Q3 2015 | 52.02 % | 28.83 % | 25.77 % |
Q4 2015 | 51.12 % | 26.62 % | 24.44 % |
Q1 2016 | 51.39 % | 28.30 % | 24.72 % |
Q2 2016 | 51.82 % | 22.50 % | 18.06 % |
Q3 2016 | 52.60 % | 28.28 % | 26.29 % |
Q4 2016 | 49.36 % | 25.48 % | 20.92 % |
Q1 2017 | 45.86 % | 31.64 % | 27.94 % |
Q2 2017 | 39.46 % | 22.25 % | 17.64 % |
Q3 2017 | 37.76 % | 21.46 % | 18.38 % |
Q4 2017 | 39.90 % | 25.53 % | 22.68 % |
Q1 2018 | 40.60 % | 27.04 % | 22.05 % |
Q2 2018 | 33.78 % | 15.35 % | 9.90 % |
Q3 2018 | 33.02 % | 13.01 % | 5.95 % |
Q4 2018 | 35.91 % | 15.33 % | 9.88 % |
Q1 2019 | 29.02 % | 11.44 % | 4.17 % |
Q2 2019 | 29.09 % | 9.62 % | 3.48 % |
Q3 2019 | 31.02 % | 15.07 % | 8.59 % |
Q4 2019 | 36.55 % | 17.05 % | 11.18 % |
Q1 2020 | 33.66 % | 11.59 % | 4.85 % |
Q2 2020 | 32.28 % | 15.23 % | 4.38 % |
Q3 2020 | 34.93 % | 15.45 % | 7.09 % |
Q4 2020 | 30.99 % | 11.40 % | 2.13 % |
Q1 2021 | 29.44 % | 8.41 % | (1.30 %) |
Q2 2021 | 33.43 % | 11.79 % | 2.11 % |
Q3 2021 | 34.54 % | 12.53 % | 3.71 % |
Q4 2021 | 32.09 % | 6.10 % | (3.86 %) |
Q1 2022 | 32.15 % | 13.30 % | 3.99 % |
Q2 2022 | 31.25 % | 10.84 % | 2.05 % |
Q3 2022 | 29.71 % | 12.63 % | 2.17 % |
Q4 2022 | 33.01 % | 16.05 % | 5.37 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2013 | - | - | - | - |
Q2 2013 | - | - | - | - |
Q3 2013 | - | - | - | - |
Q4 2013 | - | - | - | - |
Q1 2014 | 92.04 | - | - | 10.70 |
Q2 2014 | 92.04 | - | - | 11.69 |
Q3 2014 | 92.04 | - | - | 12.48 |
Q4 2014 | 92.04 | 3.61 | 3.61 | 12.38 |
Q1 2015 | 92.04 | 3.88 | 3.88 | 13.50 |
Q2 2015 | 92.04 | 3.87 | 3.87 | 12.67 |
Q3 2015 | 92.04 | 4.05 | 4.05 | 13.63 |
Q4 2015 | 92.04 | 4.24 | 4.24 | 14.70 |
Q1 2016 | 92.04 | 4.23 | 4.23 | 16.39 |
Q2 2016 | 92.04 | 4.03 | 4.03 | 15.20 |
Q3 2016 | 92.04 | 4.13 | 4.13 | 16.43 |
Q4 2016 | 92.04 | 3.94 | 3.94 | 17.32 |
Q1 2017 | 92.04 | 4.00 | 4.00 | 18.46 |
Q2 2017 | 92.04 | 3.87 | 3.87 | 17.09 |
Q3 2017 | 92.04 | 3.49 | 3.49 | 17.74 |
Q4 2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Q1 2018 | 92.04 | 3.22 | 3.22 | 16.69 |
Q2 2018 | 92.04 | 2.92 | 2.92 | 15.07 |
Q3 2018 | 92.04 | 2.44 | 2.44 | 15.29 |
Q4 2018 | 92.04 | 1.87 | 1.87 | 15.71 |
Q1 2019 | 92.04 | 1.08 | 1.08 | 15.87 |
Q2 2019 | 92.04 | 0.84 | 0.84 | 16.00 |
Q3 2019 | 92.04 | 0.99 | 0.99 | 16.36 |
Q4 2019 | 92.04 | 1.06 | 1.15 | 16.54 |
Q1 2020 | 92.04 | 1.13 | 1.22 | 16.77 |
Q2 2020 | 92.04 | 1.18 | 1.26 | 16.95 |
Q3 2020 | 92.04 | 1.19 | 1.28 | 17.33 |
Q4 2020 | 92.04 | 0.89 | 0.89 | 13.38 |
Q1 2021 | 92.04 | 0.79 | 0.60 | 13.51 |
Q2 2021 | 92.04 | 0.71 | 0.53 | 13.61 |
Q3 2021 | 92.04 | 0.49 | 0.35 | 13.77 |
Q4 2021 | 92.04 | 0.19 | 0.04 | 13.66 |
Q1 2022 | 92.04 | 0.28 | 0.32 | 13.89 |
Q2 2022 | 92.04 | 0.29 | 0.33 | 13.92 |
Q3 2022 | 92.04 | 0.26 | 0.25 | 14.04 |
Q4 2022 | 92.04 | 0.82 | 0.82 | 14.83 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2013 | 92.04 | 1.49 | 1.49 | 9.84 |
2014 | 92.04 | 3.61 | 3.61 | 12.38 |
2015 | 92.04 | 4.24 | 4.24 | 14.70 |
2016 | 92.04 | 3.94 | 3.94 | 17.32 |
2017 | 92.04 | 3.47 | 3.47 | 15.75 |
2018 | 92.04 | 1.87 | 1.87 | 15.71 |
2019 | 92.04 | 1.06 | 1.15 | 16.54 |
2020 | 92.04 | 0.89 | 0.89 | 13.38 |
2021 | 92.04 | 0.19 | 0.04 | 13.66 |
2022 | 92.04 | 0.82 | 0.82 | 14.83 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | 17.17 | 17.17 | 4.43 |
Q2 2016 | 17.16 | 17.16 | 4.56 |
Q3 2016 | 12.41 | 12.41 | 3.12 |
Q4 2016 | 18.62 | 18.62 | 4.23 |
Q1 2017 | 18.48 | 18.48 | 4.01 |
Q2 2017 | 19.45 | 19.45 | 4.41 |
Q3 2017 | 17.98 | 17.98 | 3.54 |
Q4 2017 | 15.52 | 15.52 | 3.42 |
Q1 2018 | 17.90 | 17.90 | 3.46 |
Q2 2018 | 20.02 | 20.02 | 3.88 |
Q3 2018 | 15.00 | 15.00 | 2.39 |
Q4 2018 | 17.34 | 17.34 | 2.07 |
Q1 2019 | 29.49 | 29.49 | 2.01 |
Q2 2019 | 32.63 | 32.63 | 1.72 |
Q3 2019 | 26.36 | 26.36 | 1.59 |
Q4 2019 | 28.02 | 25.89 | 1.80 |
Q1 2020 | 22.49 | 20.89 | 1.52 |
Q2 2020 | 25.77 | 23.99 | 1.79 |
Q3 2020 | 30.69 | 28.61 | 2.11 |
Q4 2020 | 39.35 | 39.35 | 2.62 |
Q1 2021 | 44.44 | 58.50 | 2.60 |
Q2 2021 | 54.85 | 74.08 | 2.88 |
Q3 2021 | 77.28 | More than 100 | 2.75 |
Q4 2021 | More than 100 | More than 100 | 2.32 |
Q1 2022 | More than 100 | More than 100 | 2.34 |
Q2 2022 | More than 100 | 98.17 | 2.31 |
Q3 2022 | More than 100 | More than 100 | 1.94 |
Q4 2022 | 31.16 | 31.16 | 1.72 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | 18.62 | 18.62 | 4.23 |
2017 | 15.52 | 15.52 | 3.42 |
2018 | 17.34 | 17.34 | 2.07 |
2019 | 28.02 | 25.89 | 1.80 |
2020 | 39.34 | 39.34 | 2.62 |
2021 | More than 100 | More than 100 | 2.32 |
2022 | 31.16 | 31.16 | 1.72 |
Q4 2022
2022
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
Q1 2014 | 207.07 | 85.01 | 64.94 | 2.16 |
Q2 2014 | 200.50 | 77.40 | 66.66 | 2.51 |
Q1 2015 | 224.99 | 91.95 | 70.24 | 4.46 |
Q2 2015 | 211.41 | 86.64 | 70.30 | 3.65 |
Q3 2015 | 200.38 | 85.53 | 63.54 | 2.76 |
Q4 2015 | 220.47 | 119.55 | 72.94 | 5.72 |
Q1 2016 | 241.22 | 100.20 | 73.04 | 7.06 |
Q2 2016 | 229.99 | 99.85 | 72.93 | 7.31 |
Q3 2016 | 224.32 | 89.88 | 62.16 | 2.72 |
Q4 2016 | 220.91 | 107.73 | 72.64 | 3.69 |
Q1 2017 | 242.80 | 104.89 | 71.94 | 4.27 |
Q2 2017 | 224.48 | 92.89 | 70.77 | 3.54 |
Q3 2017 | 133.39 | 85.39 | 60.16 | 3.27 |
Q4 2017 | 172.44 | 114.51 | 71.35 | 6.30 |
Q1 2018 | 214.32 | 109.10 | 68.50 | 3.20 |
Q2 2018 | 188.62 | 79.63 | 76.10 | 1.78 |
Q3 2018 | 184.16 | 98.93 | 53.64 | 2.04 |
Q4 2018 | 147.36 | 97.71 | 61.91 | 3.70 |
Q1 2019 | 181.07 | 97.28 | 67.29 | 4.54 |
Q2 2019 | 185.66 | 95.13 | 68.96 | 3.44 |
Q3 2019 | 223.51 | 95.92 | 64.81 | 2.51 |
Q4 2019 | 222.02 | 111.18 | 69.80 | 3.51 |
Q1 2020 | 264.27 | 98.09 | 71.34 | 2.60 |
Q2 2020 | 238.16 | 70.59 | 61.71 | 2.81 |
Q3 2020 | 301.73 | 111.20 | 76.35 | 2.85 |
Q4 2020 | 281.15 | 110.99 | 74.56 | 3.81 |
Q1 2021 | 236.94 | 115.00 | 61.88 | 4.54 |
Q2 2021 | 284.69 | 102.17 | 67.31 | 2.40 |
Q3 2021 | 292.19 | 139.00 | 61.71 | 5.83 |
Q4 2021 | 284.48 | 135.06 | 74.52 | 4.89 |
Q1 2022 | 290.29 | 141.03 | 78.90 | 3.10 |
Q2 2022 | 294.67 | 138.11 | 73.11 | 2.20 |
Q3 2022 | 293.31 | 145.39 | 71.94 | 1.74 |
Q4 2022 | 360.72 | 163.35 | 89.59 | 4.30 |
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
2013 | - | - | 159.08 | 1.19 |
2014 | 807.92 | 323.31 | 257.32 | 10.20 |
2015 | 857.25 | 383.67 | 277.02 | 16.59 |
2016 | 916.44 | 397.66 | 280.76 | 20.77 |
2017 | 773.12 | 397.68 | 274.21 | 17.38 |
2018 | 734.45 | 385.37 | 260.14 | 10.73 |
2019 | 812.27 | 399.51 | 270.86 | 14.01 |
2020 | 1,085.30 | 390.88 | 283.96 | 12.07 |
2021 | 1,098.30 | 491.24 | 265.42 | 17.66 |
2022 | 1,238.98 | 587.88 | 313.54 | 11.34 |
Item | Q4 2022 (e) | Q4 2022 (a) | Change |
---|---|---|---|
Average | 17.23 | 33.16 | 92.52 % |
Item | Q4 2022 (e) | Q4 2022 (a) | Change |
---|---|---|---|
Hermes | 26.00 | 33.16 | 27.5 % |
SNB Capital | 16.60 | 33.16 | 99.8 % |
AlJazira Capital | 14.20 | 33.16 | 133.5 % |
U-Capital | 12.10 | 33.16 | 174.1 % |
Current | |
Market Cap (M Riyal) | 6,488.82 |
Enterprise Value (EV) (M) | 8,884.32 |
Shares Outstanding ((M)) | 92.04 |
EPS ( Riyal) (TTM) | 2.30 |
Book Value (BV) ( Riyal) | 18.46 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 33.80 |
P/E (TTM) | 30.70 |
Price/book | 3.82 |
Return on Average Assets (%) (TTM) | 4.2 |
Return on Average Equity (%) (TTM) | 13.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}